நடுக்குவாதம் (Tamil Wikipedia)

Analysis of information sources in references of the Wikipedia article "நடுக்குவாதம்" in Tamil language version.

refsWebsite

Global rank Tamil rank

4^th place

5^th place

2^nd place

4^th place

6^th place

8^th place

6web.archive.org

1^st place

1^st place

low place

low place

9,919^th place

4,441^st place

3,257^th place

530^th place

2oxfordjournals.org

1,389^th place

213^th place

3,258^th place

310^th place

1medicalnewstoday.com

3,011^th place

536^th place

low place

low place

1sciencedirect.com

149^th place

253^rd place

4,455^th place

2,197^th place

low place

6,134^th place

low place

low place

1touchneurology.com

low place

low place

low place

3,795^th place

1pubmedcentral.gov

low place

131^st place

1bentham-direct.org

low place

low place

low place

low place

1holisticonline.com

low place

3,162^nd place

1psychiatryonline.org

4,032^nd place

2,253^rd place

1springerlink.com

2,569^th place

384^th place

230^th place

85^th place

1coffeetownpress.com

low place

low place

61^st place

180^th place

1castleconnollyawards.com

low place

low place

low place

low place

low place

low place

ama-assn.org

archneur.ama-assn.org

Hulya Apaydin, MD; J. Eric Ahlskog, PhD, MD; Joseph E. Parisi, MD; Bradley F. Boeve, MD; Dennis W. Dickson, MD. "Parkinson Disease Neuropathology; Later-Developing Dementia and Loss of the Levodopa Response". Archives of Neurology. பப்மெட்:11790237. http://archneur.ama-assn.org/cgi/content/abstract/59/1/102.
http://archneur.ama-assn.org/cgi/content/abstract/45/12/1321

archive.org

Frank MJ (2005). "Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism". Journal of cognitive neuroscience 17 (1): 51–72. doi:10.1162/0898929052880093. பப்மெட்:15701239. https://archive.org/details/sim_journal-of-cognitive-neuroscience_2005-01_17_1/page/51.
Pell M (1996). "On the receptive prosodic loss in Parkinson's disease". Cortex 32 (4): 693–704. பப்மெட்:8954247. https://archive.org/details/sim_cortex_1996-12_32_4/page/693.
Ascherio A, Chen H, Weisskopf M, et al (2006). "Pesticide exposure and risk for Parkinson's disease". Ann Neurol 60 (2): 197–203. doi:10.1002/ana.20904. பப்மெட்:16802290. https://archive.org/details/sim_annals-of-neurology_2006-08_60_2/page/197.
Chiueh C, Wu R, Mohanakumar K, Sternberger L, Krishna G, Obata T, Murphy D (1994). "In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia". Ann N Y Acad Sci 738: 25–36. பப்மெட்:7832434. https://archive.org/details/sim_annals-of-the-new-york-academy-of-sciences_1994_738/page/25.
Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW (2006). "Head injury and Parkinson's disease risk in twins". Ann. Neurol. 60 (1): 65–72. doi:10.1002/ana.20882. பப்மெட்:16718702. https://archive.org/details/sim_annals-of-neurology_2006-07_60_1/page/65.
Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". Semin Speech Lang 27 (4): 283–99. doi:10.1055/s-2006-955118. பப்மெட்:17117354. https://archive.org/details/sim_seminars-in-speech-and-language_2006-11_27_4/page/283.
Goetz CG, Stebbins GT (1995). "Mortality and hallucinations in nursing home patients with advanced Parkinson's disease". Neurology 45 (4): 669–71. பப்மெட்:7723953. https://archive.org/details/sim_neurology_1995-04_45_4/page/669.

bentham-direct.org

Schulz GM (July 2002). "The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature". Curr. Med. Chem. 9 (14): 1359–66. பப்மெட்:12132992. http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM. பார்த்த நாள்: 2021-12-25.

castleconnollyawards.com

"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2012-01-14. பார்க்கப்பட்ட நாள் 2010-04-15.

coffeetownpress.com

http://coffeetownpress.com/natural-therapies-for-parkinsons-disease/

doi.org

dx.doi.org

Jankovic J (April 2008). "Parkinson's disease: clinical features and diagnosis". J. Neurol. Neurosurg. Psychiatr. 79 (4): 368–76. doi:10.1136/jnnp.2007.131045. பப்மெட்:18344392.
Lepoutre A, Devos D, Blanchard-Dauphin A, et al (2006). "A specific clinical pattern of camptocormia in Parkinson's disease". J. Neurol. Neurosurg. Psychiatr. 77 (11): 1229–34. doi:10.1136/jnnp.2005.083998. பப்மெட்:16735399.
Aarsland D, Brønnick K, Ehrt U, et al. (January 2007). "Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress". J. Neurol. Neurosurg. Psychiatr. 78 (1): 36–42. doi:10.1136/jnnp.2005.083113. பப்மெட்:16820421.
Frank MJ (2005). "Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism". Journal of cognitive neuroscience 17 (1): 51–72. doi:10.1162/0898929052880093. பப்மெட்:15701239. https://archive.org/details/sim_journal-of-cognitive-neuroscience_2005-01_17_1/page/51.
Lieberman A (January 2006). "Depression in Parkinson's disease -- a review". Acta Neurol. Scand. 113 (1): 1–8. doi:10.1111/j.1600-0404.2006.00536.x. பப்மெட்:16367891.
Ishihara L, Brayne C (2006). "A systematic review of depression and mental illness preceding Parkinson's disease". Acta Neurol Scand 113 (4): 211–20. doi:10.1111/j.1600-0404.2006.00579.x. பப்மெட்:16542159.
Gupta A, Bluhm R (2004). "Seborrheic dermatitis". Journal of the European Academy of Dermatology and Venereology : JEADV 18 (1): 13–26; quiz 19–20. doi:10.1111/j.1468-3083.2004.00693.x. பப்மெட்:14678527.
லெபொவியர் டி, சாமெட்டெ டி, பெய்ல்லுசன் எஸ், டைக்கார்ட்ஸ் சி, ப்ரூலே டெஸ் வாரன்னெஸ் எஸ், நியூன்லிஸ்ட் எம், டெர்கிண்டரென் பி. (2009). த செகண்ட் பிரெயின் அண்ட் பார்கின்சன்'ஸ் டிசீஸ். இயுர் ஜெ நியூரோஸ்கி. 30(5):735-41. PubMed எஆசு:10.1111/j.1460-9568.2009.06873.x
Ascherio A, Chen H, Weisskopf M, et al (2006). "Pesticide exposure and risk for Parkinson's disease". Ann Neurol 60 (2): 197–203. doi:10.1002/ana.20904. பப்மெட்:16802290. https://archive.org/details/sim_annals-of-neurology_2006-08_60_2/page/197.
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000). "Chronic systemic pesticide exposure reproduces features of Parkinson's disease". Nat. Neurosci. 3 (12): 1301–6. doi:10.1038/81834. பப்மெட்:11100151.
Kitazawa M, Anantharam V, Kanthasamy AG (2001). "Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells". Free Radic. Biol. Med. 31 (11): 1473–85. doi:10.1016/S0891-5849(01)00726-2. பப்மெட்:11728820. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T38-44HSN76-P&_coverDate=12%2F01%2F2001&_alid=373422978&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4940&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5a104ac89bd7948e14863371142a639a. பார்த்த நாள்: 2010-04-15.
Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002). "The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein". J. Biol. Chem. 277 (3): 1641–4. doi:10.1074/jbc.C100560200. பப்மெட்:11707429. http://www.jbc.org/cgi/content/full/277/3/1641. பார்த்த நாள்: 2010-04-15.
Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000). "Organochlorine insecticides in substantia nigra in Parkinson's disease". J. Toxicol. Environ. Health Part A 59 (4): 229–34. doi:10.1080/009841000156907. பப்மெட்:10706031. http://journalsonline.tandf.co.uk/openurl.asp?genre=article&eissn=1087-2620&volume=59&issue=4&spage=229. ^{[தொடர்பிழந்த இணைப்பு]}
Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW (2006). "Head injury and Parkinson's disease risk in twins". Ann. Neurol. 60 (1): 65–72. doi:10.1002/ana.20882. பப்மெட்:16718702. https://archive.org/details/sim_annals-of-neurology_2006-07_60_1/page/65.
Kaur D, Andersen J (2002). "Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?" (PDF). Aging Cell 1 (1): 17–21. doi:10.1046/j.1474-9728.2002.00001.x. பப்மெட்:12882349. http://doi.org/10.1046/j.1474-9728.2002.00001.x.
Masliah E, Rockenstein E, Veinbergs I, et al (2000). "Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders". Science 287 (5456): 1265–9. doi:10.1126/science.287.5456.1265. பப்மெட்:10678833.
Gelb D, Oliver E, Gilman S (1999). "Diagnostic criteria for Parkinson disease". Arch Neurol 56 (1): 33–9. doi:10.1001/archneur.56.1.33. பப்மெட்:9923759.
Guridi J, Obeso JA (2001). "The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma". Brain 124 (Pt 1): 5–19. doi:10.1093/brain/124.1.5. பப்மெட்:11133783. http://brain.oxfordjournals.org/cgi/content/full/124/1/5.
Deane KH, Jones D, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "Physiotherapy for patients with Parkinson's Disease: a comparison of techniques". Cochrane Database Syst Rev (3): CD002817. doi:10.1002/14651858.CD002817. பப்மெட்:11687029.
Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease". Cochrane Database Syst Rev (2): CD002814. doi:10.1002/14651858.CD002814. பப்மெட்:11406045.
Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (April 2008). "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis". Mov. Disord. 23 (5): 631–40. doi:10.1002/mds.21922. பப்மெட்:18181210.
Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". Semin Speech Lang 27 (4): 283–99. doi:10.1055/s-2006-955118. பப்மெட்:17117354. https://archive.org/details/sim_seminars-in-speech-and-language_2006-11_27_4/page/283.
Parkinson J (2002). "An essay on the shaking palsy. 1817" (Reproduced). J Neuropsychiatry Clin Neurosci 14 (2): 223–36; discussion 222. doi:10.1176/appi.neuropsych.14.2.223. பப்மெட்:11983801. http://neuro.psychiatryonline.org/cgi/content/full/14/2/223. பார்த்த நாள்: 2010-04-15.
Hornykiewicz O (2002). "L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent". Amino Acids 23 (1-3): 65–70. doi:10.1007/s00726-001-0111-9. பப்மெட்:12373520.
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ (2007). "Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial". Lancet 369 (9579): 2097–105. doi:10.1016/S0140-6736(07)60982-9. பப்மெட்:17586305.
Djaldetti R, Melamed E (2002). "New drugs in the future treatment of Parkinson's disease". J. Neurol. 249 Suppl 2: II30–5. doi:10.1007/s00415-002-1206-2. பப்மெட்:12375061.
Redmond E et al (2007). "Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells". Proceedings of the National Academy of Sciences 104 (29): 12175. doi:10.1073/pnas.0704091104. பப்மெட்:17586681.
Birkmayer W, Birkmayer JG (1986). "Iron, a new aid in the treatment of Parkinson patients". J. Neural Transm. 67 (3-4): 287–92. doi:10.1007/BF01243354. பப்மெட்:3806082. http://www.springerlink.com/link.asp?id=tp15r2g8u6327731. ^{[தொடர்பிழந்த இணைப்பு]}
Schmitz-Hubsch T (2006). "Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study". Mov Disord 21 (4): 543–548. doi:10.1002/mds.20705. பப்மெட்:16229022.
Katzenschlager R, Evans A, Manson A, et al (2004). "Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study". J. Neurol. Neurosurg. Psychiatr. 75 (12): 1672–7. doi:10.1136/jnnp.2003.028761. பப்மெட்:15548480.

doi.org

Kaur D, Andersen J (2002). "Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?" (PDF). Aging Cell 1 (1): 17–21. doi:10.1046/j.1474-9728.2002.00001.x. பப்மெட்:12882349. http://doi.org/10.1046/j.1474-9728.2002.00001.x.

hhmi.org

"பார்கின்சன்'ஸ் டிசீஸ் மெக்கானிசம் டிஸ்கவர்ட்," HHMI ஆய்வுச் செய்திகள் ஜூன் 22, 2006.

holisticonline.com

http://holisticonline.com/Remedies/Parkinson/pd_who-gets.htm

jbc.org

Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002). "The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein". J. Biol. Chem. 277 (3): 1641–4. doi:10.1074/jbc.C100560200. பப்மெட்:11707429. http://www.jbc.org/cgi/content/full/277/3/1641. பார்த்த நாள்: 2010-04-15.

jneurosci.org

Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (2000). "The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease". J. Neurosci. 20 (24): 9207–14. பப்மெட்:11124998. http://www.jneurosci.org/cgi/content/full/20/24/9207.

mayo.edu

cancercenter.mayo.edu

"Parkinson's Disease". Mayo Clinic: College of Medicine. Archived from the original on 2006-09-04. பார்க்கப்பட்ட நாள் 2006-11-04.

medicalnewstoday.com

Orr, Leslie (February 10, 2005). "PCBs, fungicide open brain cells to Parkinson's assault". Medical News Today இம் மூலத்தில் இருந்து பிப்ரவரி 27, 2005 அன்று. பரணிடப்பட்டது.. https://web.archive.org/web/20050227045313/http://www.medicalnewstoday.com/medicalnews.php?newsid=19791.

neurology.org

Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA (2003). "Head trauma preceding PD: a case-control study" (abstract page). Neurology 60 (10): 1610–5. பப்மெட்:12771250. http://www.neurology.org/cgi/content/abstract/60/10/1610. பார்த்த நாள்: 2010-04-15.
Cleanthe Spanaki, MD, PhD; Helen Latsoudis, MSc, PhD; Andreas Plaitakis, MD, PhD. "LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP". Neurology. பப்மெட்:17060595. http://www.neurology.org/cgi/content/full/67/8/1518?. பார்த்த நாள்: 2010-04-15.

nice.org.uk

guidance.nice.org.uk

National Institute for Health and Clinical Excellence. Clinical guideline 35: Parkinson's disease. London, June 2006.

nih.gov

ncbi.nlm.nih.gov

Jankovic J (April 2008). "Parkinson's disease: clinical features and diagnosis". J. Neurol. Neurosurg. Psychiatr. 79 (4): 368–76. doi:10.1136/jnnp.2007.131045. பப்மெட்:18344392.
Lepoutre A, Devos D, Blanchard-Dauphin A, et al (2006). "A specific clinical pattern of camptocormia in Parkinson's disease". J. Neurol. Neurosurg. Psychiatr. 77 (11): 1229–34. doi:10.1136/jnnp.2005.083998. பப்மெட்:16735399.
Aarsland D, Brønnick K, Ehrt U, et al. (January 2007). "Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress". J. Neurol. Neurosurg. Psychiatr. 78 (1): 36–42. doi:10.1136/jnnp.2005.083113. பப்மெட்:16820421.
Frank MJ (2005). "Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism". Journal of cognitive neuroscience 17 (1): 51–72. doi:10.1162/0898929052880093. பப்மெட்:15701239. https://archive.org/details/sim_journal-of-cognitive-neuroscience_2005-01_17_1/page/51.
Pell M (1996). "On the receptive prosodic loss in Parkinson's disease". Cortex 32 (4): 693–704. பப்மெட்:8954247. https://archive.org/details/sim_cortex_1996-12_32_4/page/693.
Lieberman A (January 2006). "Depression in Parkinson's disease -- a review". Acta Neurol. Scand. 113 (1): 1–8. doi:10.1111/j.1600-0404.2006.00536.x. பப்மெட்:16367891.
Ishihara L, Brayne C (2006). "A systematic review of depression and mental illness preceding Parkinson's disease". Acta Neurol Scand 113 (4): 211–20. doi:10.1111/j.1600-0404.2006.00579.x. பப்மெட்:16542159.
Gupta A, Bluhm R (2004). "Seborrheic dermatitis". Journal of the European Academy of Dermatology and Venereology : JEADV 18 (1): 13–26; quiz 19–20. doi:10.1111/j.1468-3083.2004.00693.x. பப்மெட்:14678527.
பிஃபெய்ஃபர் ஆர்எஃப். (2003). கேஸ்ட்ரோஇன்டெஸ்டினல் டிஸ்ஃபங்க்சன் இன் பார்கின்சன்'ஸ் டிசீஸ். லாண்செட் நியூரல். 2(2):107-16. PubMed
லெபொவியர் டி, சாமெட்டெ டி, பெய்ல்லுசன் எஸ், டைக்கார்ட்ஸ் சி, ப்ரூலே டெஸ் வாரன்னெஸ் எஸ், நியூன்லிஸ்ட் எம், டெர்கிண்டரென் பி. (2009). த செகண்ட் பிரெயின் அண்ட் பார்கின்சன்'ஸ் டிசீஸ். இயுர் ஜெ நியூரோஸ்கி. 30(5):735-41. PubMed எஆசு:10.1111/j.1460-9568.2009.06873.x
Di Monte DA, Lavasani M, Manning-Bog AB (2001). "Environmental factors in Parkinson's disease". Neurotoxicology 23 (4-5): 487–502. பப்மெட்:12428721.
Jenner P (1998). "Oxidative mechanisms in nigral cell death in Parkinson's disease". Mov. Disord. 13 Suppl 1: 24–34. பப்மெட்:9613715.
Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G (2000). "Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals". Neurotoxicity research 2 (2-3): 293–310. பப்மெட்:16787846.
Cotzias G (1966). "Manganese, melanins and the extrapyramidal system". J Neurosurg 24 (1): Suppl:170–80. பப்மெட்:4955707.
Barbeau A (1984). "Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias)". Neurotoxicology 5 (1): 13–35. பப்மெட்:6538948.
Ascherio A, Chen H, Weisskopf M, et al (2006). "Pesticide exposure and risk for Parkinson's disease". Ann Neurol 60 (2): 197–203. doi:10.1002/ana.20904. பப்மெட்:16802290. https://archive.org/details/sim_annals-of-neurology_2006-08_60_2/page/197.
Chiueh C, Wu R, Mohanakumar K, Sternberger L, Krishna G, Obata T, Murphy D (1994). "In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia". Ann N Y Acad Sci 738: 25–36. பப்மெட்:7832434. https://archive.org/details/sim_annals-of-the-new-york-academy-of-sciences_1994_738/page/25.
Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (2000). "The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease". J. Neurosci. 20 (24): 9207–14. பப்மெட்:11124998. http://www.jneurosci.org/cgi/content/full/20/24/9207.
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000). "Chronic systemic pesticide exposure reproduces features of Parkinson's disease". Nat. Neurosci. 3 (12): 1301–6. doi:10.1038/81834. பப்மெட்:11100151.
Kitazawa M, Anantharam V, Kanthasamy AG (2001). "Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells". Free Radic. Biol. Med. 31 (11): 1473–85. doi:10.1016/S0891-5849(01)00726-2. பப்மெட்:11728820. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T38-44HSN76-P&_coverDate=12%2F01%2F2001&_alid=373422978&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4940&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5a104ac89bd7948e14863371142a639a. பார்த்த நாள்: 2010-04-15.
Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002). "The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein". J. Biol. Chem. 277 (3): 1641–4. doi:10.1074/jbc.C100560200. பப்மெட்:11707429. http://www.jbc.org/cgi/content/full/277/3/1641. பார்த்த நாள்: 2010-04-15.
Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000). "Organochlorine insecticides in substantia nigra in Parkinson's disease". J. Toxicol. Environ. Health Part A 59 (4): 229–34. doi:10.1080/009841000156907. பப்மெட்:10706031. http://journalsonline.tandf.co.uk/openurl.asp?genre=article&eissn=1087-2620&volume=59&issue=4&spage=229. ^{[தொடர்பிழந்த இணைப்பு]}
மெர்குரி அமல்கம் டெண்டல் ஃபில்லிங்ஸ்: ஆன் எபிடெமிலாஜிக் அசெஸ்மண்ட்.
பர்கின்சன்'ஸ் டிசீஸ், மாகுலர் டிஜெனெரேசன் அண்ட் கியூடனியஸ் சைன்ஸ் ஆஃப் மெர்க்குரி டாக்சிசிட்டி.
த எனிக்மா ஆஃப் பார்கின்சோனிசம் இன் குரோனிக் பார்டர்லைன் மெர்க்குரி இண்டாக்சிகேசன், ரிசால்வ்ட் பை சேலஞ்ச் வித் பெனிசில்லமைன்.
Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA (2003). "Head trauma preceding PD: a case-control study" (abstract page). Neurology 60 (10): 1610–5. பப்மெட்:12771250. http://www.neurology.org/cgi/content/abstract/60/10/1610. பார்த்த நாள்: 2010-04-15.
Stern M, Dulaney E, Gruber SB, et al (1991). "The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients". Arch. Neurol. 48 (9): 903–7. பப்மெட்:url=http://archneur.ama-assn.org/cgi/content/abstract/48/9/903 1953412 url=http://archneur.ama-assn.org/cgi/content/abstract/48/9/903.
Uryu K, Giasson BI, Longhi L, et al (2003). "Age-dependent synuclein pathology following traumatic brain injury in mice". Exp. Neurol. 184 (1): 214–24. பப்மெட்:14637093.
Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW (2006). "Head injury and Parkinson's disease risk in twins". Ann. Neurol. 60 (1): 65–72. doi:10.1002/ana.20882. பப்மெட்:16718702. https://archive.org/details/sim_annals-of-neurology_2006-07_60_1/page/65.
Kaur D, Andersen J (2002). "Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?" (PDF). Aging Cell 1 (1): 17–21. doi:10.1046/j.1474-9728.2002.00001.x. பப்மெட்:12882349. http://doi.org/10.1046/j.1474-9728.2002.00001.x.
Masliah E, Rockenstein E, Veinbergs I, et al (2000). "Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders". Science 287 (5456): 1265–9. doi:10.1126/science.287.5456.1265. பப்மெட்:10678833.
Gelb D, Oliver E, Gilman S (1999). "Diagnostic criteria for Parkinson disease". Arch Neurol 56 (1): 33–9. doi:10.1001/archneur.56.1.33. பப்மெட்:9923759.
Marvin M. Goldenberg, PhD, RPh, MS (October 2008). Pharmacy and Therapeutics 33 (10). பப்மெட்:19750042. பப்மெட் சென்ட்ரல்:2730785. Medical Management of Parkinson’s Disease.
Thorogood M, Armstrong B, Nichols T, Hollowell J (1998). "Mortality in people taking selegiline: observational study". BMJ 317 (7153): 252–4. பப்மெட்:9677215.
Marras C, McDermott M, Rochon P, Tanner C, Naglie G, Rudolph A, Lang A (2005). "Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort". Neurology 64 (1): 87–93. பப்மெட்:15642909.
Guridi J, Obeso JA (2001). "The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma". Brain 124 (Pt 1): 5–19. doi:10.1093/brain/124.1.5. பப்மெட்:11133783. http://brain.oxfordjournals.org/cgi/content/full/124/1/5.
Fukuda M, Kameyama S, Yoshino M, Tanaka R, Narabayashi H (2000). "Neuropsychological outcome following pallidotomy and thalamotomy for Parkinson's disease". Stereotactic and functional neurosurgery 74 (1): 11–20. பப்மெட்:11124660.
Deane KH, Jones D, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "Physiotherapy for patients with Parkinson's Disease: a comparison of techniques". Cochrane Database Syst Rev (3): CD002817. doi:10.1002/14651858.CD002817. பப்மெட்:11687029.
Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease". Cochrane Database Syst Rev (2): CD002814. doi:10.1002/14651858.CD002814. பப்மெட்:11406045.
Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (April 2008). "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis". Mov. Disord. 23 (5): 631–40. doi:10.1002/mds.21922. பப்மெட்:18181210.
Schulz GM (July 2002). "The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature". Curr. Med. Chem. 9 (14): 1359–66. பப்மெட்:12132992. http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM. பார்த்த நாள்: 2021-12-25.
Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". Semin Speech Lang 27 (4): 283–99. doi:10.1055/s-2006-955118. பப்மெட்:17117354. https://archive.org/details/sim_seminars-in-speech-and-language_2006-11_27_4/page/283.
Hulya Apaydin, MD; J. Eric Ahlskog, PhD, MD; Joseph E. Parisi, MD; Bradley F. Boeve, MD; Dennis W. Dickson, MD. "Parkinson Disease Neuropathology; Later-Developing Dementia and Loss of the Levodopa Response". Archives of Neurology. பப்மெட்:11790237. http://archneur.ama-assn.org/cgi/content/abstract/59/1/102.
Cleanthe Spanaki, MD, PhD; Helen Latsoudis, MSc, PhD; Andreas Plaitakis, MD, PhD. "LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP". Neurology. பப்மெட்:17060595. http://www.neurology.org/cgi/content/full/67/8/1518?. பார்த்த நாள்: 2010-04-15.
Goetz CG, Stebbins GT (1995). "Mortality and hallucinations in nursing home patients with advanced Parkinson's disease". Neurology 45 (4): 669–71. பப்மெட்:7723953. https://archive.org/details/sim_neurology_1995-04_45_4/page/669.
McInerney-Leo A, Gwinn-Hardy K, Nussbaum RL (July 2004). "Prevalence of Parkinson's disease in populations of African ancestry: a review". J Natl Med Assoc 96 (7): 974–9. பப்மெட்:15253330.
Manyam BV, Sánchez-Ramos JR (1999). "Traditional and complementary therapies in Parkinson's disease". Advances in neurology 80: 565–74. பப்மெட்:10410773.
Parkinson J (2002). "An essay on the shaking palsy. 1817" (Reproduced). J Neuropsychiatry Clin Neurosci 14 (2): 223–36; discussion 222. doi:10.1176/appi.neuropsych.14.2.223. பப்மெட்:11983801. http://neuro.psychiatryonline.org/cgi/content/full/14/2/223. பார்த்த நாள்: 2010-04-15.
Hornykiewicz O (2002). "L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent". Amino Acids 23 (1-3): 65–70. doi:10.1007/s00726-001-0111-9. பப்மெட்:12373520.
Cotzias G (1968). "L-Dopa for Parkinsonism". N Engl J Med 278 (11): 630. பப்மெட்:5637779.
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ (2007). "Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial". Lancet 369 (9579): 2097–105. doi:10.1016/S0140-6736(07)60982-9. பப்மெட்:17586305.
Djaldetti R, Melamed E (2002). "New drugs in the future treatment of Parkinson's disease". J. Neurol. 249 Suppl 2: II30–5. doi:10.1007/s00415-002-1206-2. பப்மெட்:12375061.
"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group". N. Engl. J. Med. 328 (3): 176–83. 1993. பப்மெட்:8417384.
Freed CR, Greene PE, Breeze RE, et al (2001). "Transplantation of embryonic dopamine neurons for severe Parkinson's disease". N. Engl. J. Med. 344 (10): 710–9. பப்மெட்:11236774.
Redmond DE (2002). "Cellular replacement therapy for Parkinson's disease--where we are today?". The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 8 (5): 457–88. பப்மெட்:12374430.
Redmond E et al (2007). "Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells". Proceedings of the National Academy of Sciences 104 (29): 12175. doi:10.1073/pnas.0704091104. பப்மெட்:17586681.
Birkmayer W, Birkmayer JG (1986). "Iron, a new aid in the treatment of Parkinson patients". J. Neural Transm. 67 (3-4): 287–92. doi:10.1007/BF01243354. பப்மெட்:3806082. http://www.springerlink.com/link.asp?id=tp15r2g8u6327731. ^{[தொடர்பிழந்த இணைப்பு]}
Schmitz-Hubsch T (2006). "Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study". Mov Disord 21 (4): 543–548. doi:10.1002/mds.20705. பப்மெட்:16229022.
Burini D, Farabollini B, Iacucci S, et al (2006). "A randomised controlled cross-over trial of aerobic training versus qigong in advanced Parkinson's disease". Europa medicophysica 42 (3): 231–8. பப்மெட்:17039221.
Katzenschlager R, Evans A, Manson A, et al (2004). "Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study". J. Neurol. Neurosurg. Psychiatr. 75 (12): 1672–7. doi:10.1136/jnnp.2003.028761. பப்மெட்:15548480.

pubmedcentral.nih.gov

McInerney-Leo A, Gwinn-Hardy K, Nussbaum RL (July 2004). "Prevalence of Parkinson's disease in populations of African ancestry: a review". J Natl Med Assoc 96 (7): 974–9. பப்மெட்:15253330.

nps.org.au

"Pramipexole (Sifrol) for Parkinson's disease: National Prescribing Service Ltd NPS". www.nps.org.au. பார்க்கப்பட்ட நாள் 2010-01-20.^{[தொடர்பிழந்த இணைப்பு]}

oxfordjournals.org

hmg.oxfordjournals.org

யோங்க்ஹோங்க் லி, ஆண்ட்ரீவ் க்ருபே, மற்றும் பலர் எவிடன்ஸ் தட் காமன் வேரியேசன் இன் NEDD9 இஸ் அசோசியேட்டட் வித் சஸ்செப்டிபிலிட்டி டு லேட்-ஆன்செட் அல்செய்மர்'ஸ் அண்ட் பார்கின்சன்'ஸ் டிசீஸ்

brain.oxfordjournals.org

Guridi J, Obeso JA (2001). "The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma". Brain 124 (Pt 1): 5–19. doi:10.1093/brain/124.1.5. பப்மெட்:11133783. http://brain.oxfordjournals.org/cgi/content/full/124/1/5.

pdf.org

"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2011-05-15. பார்க்கப்பட்ட நாள் 2010-04-15.

pdtrials.org

http://www.pdtrials.org/en/about_PDtrials_what

psychiatryonline.org

neuro.psychiatryonline.org

Parkinson J (2002). "An essay on the shaking palsy. 1817" (Reproduced). J Neuropsychiatry Clin Neurosci 14 (2): 223–36; discussion 222. doi:10.1176/appi.neuropsych.14.2.223. பப்மெட்:11983801. http://neuro.psychiatryonline.org/cgi/content/full/14/2/223. பார்த்த நாள்: 2010-04-15.

pubmedcentral.gov

Marvin M. Goldenberg, PhD, RPh, MS (October 2008). Pharmacy and Therapeutics 33 (10). பப்மெட்:19750042. பப்மெட் சென்ட்ரல்:2730785. Medical Management of Parkinson’s Disease.

sciencedirect.com

Kitazawa M, Anantharam V, Kanthasamy AG (2001). "Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells". Free Radic. Biol. Med. 31 (11): 1473–85. doi:10.1016/S0891-5849(01)00726-2. பப்மெட்:11728820. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T38-44HSN76-P&_coverDate=12%2F01%2F2001&_alid=373422978&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4940&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5a104ac89bd7948e14863371142a639a. பார்த்த நாள்: 2010-04-15.

springerlink.com

Birkmayer W, Birkmayer JG (1986). "Iron, a new aid in the treatment of Parkinson patients". J. Neural Transm. 67 (3-4): 287–92. doi:10.1007/BF01243354. பப்மெட்:3806082. http://www.springerlink.com/link.asp?id=tp15r2g8u6327731. ^{[தொடர்பிழந்த இணைப்பு]}

tandf.co.uk

journalsonline.tandf.co.uk

Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000). "Organochlorine insecticides in substantia nigra in Parkinson's disease". J. Toxicol. Environ. Health Part A 59 (4): 229–34. doi:10.1080/009841000156907. பப்மெட்:10706031. http://journalsonline.tandf.co.uk/openurl.asp?genre=article&eissn=1087-2620&volume=59&issue=4&spage=229. ^{[தொடர்பிழந்த இணைப்பு]}

time.com

"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2011-02-20. பார்க்கப்பட்ட நாள் 2010-04-15.

touchneurology.com

R. Cilia; et al. (2006). "Long-term Efficacy of Entacapone in Patients with Parkinson's Disease and Motor Fluctuations - A Six-Year Clinical Follow-Up Study". {{cite web}}: Explicit use of et al. in: |author= (help)^{[தொடர்பிழந்த இணைப்பு]}

uchicago.edu

home.uchicago.edu

"Dopamine biosynthesis". University of Chicago Personal Web Pages. Archived from the original (Word doc) on 2006-09-18. பார்க்கப்பட்ட நாள் 2006-11-04.

web.archive.org

Orr, Leslie (February 10, 2005). "PCBs, fungicide open brain cells to Parkinson's assault". Medical News Today இம் மூலத்தில் இருந்து பிப்ரவரி 27, 2005 அன்று. பரணிடப்பட்டது.. https://web.archive.org/web/20050227045313/http://www.medicalnewstoday.com/medicalnews.php?newsid=19791.
"Parkinson's Disease". Mayo Clinic: College of Medicine. Archived from the original on 2006-09-04. பார்க்கப்பட்ட நாள் 2006-11-04.
"Dopamine biosynthesis". University of Chicago Personal Web Pages. Archived from the original (Word doc) on 2006-09-18. பார்க்கப்பட்ட நாள் 2006-11-04.
"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2011-02-20. பார்க்கப்பட்ட நாள் 2010-04-15.
"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2012-01-14. பார்க்கப்பட்ட நாள் 2010-04-15.
"காப்பகப்படுத்தப்பட்ட நகல்". Archived from the original on 2011-05-15. பார்க்கப்பட்ட நாள் 2010-04-15.

wikipedia.org

en.wikipedia.org

Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000). "Organochlorine insecticides in substantia nigra in Parkinson's disease". J. Toxicol. Environ. Health Part A 59 (4): 229–34. doi:10.1080/009841000156907. பப்மெட்:10706031. http://journalsonline.tandf.co.uk/openurl.asp?genre=article&eissn=1087-2620&volume=59&issue=4&spage=229. ^{[தொடர்பிழந்த இணைப்பு]}
R. Cilia; et al. (2006). "Long-term Efficacy of Entacapone in Patients with Parkinson's Disease and Motor Fluctuations - A Six-Year Clinical Follow-Up Study". {{cite web}}: Explicit use of et al. in: |author= (help)^{[தொடர்பிழந்த இணைப்பு]}
"Pramipexole (Sifrol) for Parkinson's disease: National Prescribing Service Ltd NPS". www.nps.org.au. பார்க்கப்பட்ட நாள் 2010-01-20.^{[தொடர்பிழந்த இணைப்பு]}
Birkmayer W, Birkmayer JG (1986). "Iron, a new aid in the treatment of Parkinson patients". J. Neural Transm. 67 (3-4): 287–92. doi:10.1007/BF01243354. பப்மெட்:3806082. http://www.springerlink.com/link.asp?id=tp15r2g8u6327731. ^{[தொடர்பிழந்த இணைப்பு]}